Financial conflicts of interest during meetings of the cardiovascular and renal drugs advisory committee
{{output}}
Context: The Cardiovascular and Renal Drugs Advisory Committee (CRDAC) of the Food and Drug Administration (FDA) reviews safety and efficacy data for cardiovascular and renal drugs, ultimately making recommendations to the Commis... ...
